Cargando…
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles
Analysis of cancer-derived extracellular vesicles (EVs) in biofluids potentially provides a source of disease biomarkers. At present there is no procedure to systematically identify which antigens should be targeted to differentiate cancer-derived from normal host cell-derived EVs. Here, we propose...
Autores principales: | Zaborowski, Mikołaj Piotr, Lee, Kyungheon, Na, Young Jeong, Sammarco, Alessandro, Zhang, Xuan, Iwanicki, Marcin, Cheah, Pike See, Lin, Hsing-Ying, Zinter, Max, Chou, Chung-Yu, Fulci, Giulia, Tannous, Bakhos A., Lai, Charles Pin-Kuang, Birrer, Michael J., Weissleder, Ralph, Lee, Hakho, Breakefield, Xandra O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528836/ https://www.ncbi.nlm.nih.gov/pubmed/30943406 http://dx.doi.org/10.1016/j.celrep.2019.03.003 |
Ejemplares similares
-
Membrane-bound Gaussia luciferase as a tool to track shedding of membrane proteins from the surface of extracellular vesicles
por: Zaborowski, Mikołaj Piotr, et al.
Publicado: (2019) -
In vivo tomographic imaging of red-shifted fluorescent proteins
por: Deliolanis, Nikolaos C., et al.
Publicado: (2011) -
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
por: Shao, Huilin, et al.
Publicado: (2015) -
Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
por: Lai, Charles P., et al.
Publicado: (2015) -
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
por: Prabhakar, Shilpa, et al.
Publicado: (2019)